These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 3917282)

  • 1. Activation of the human classical complement pathway by a mouse monoclonal hybrid IgG1-2a monovalent anti-TNP antibody bound to TNP-conjugated cells.
    Couderc J; Kazatchkine MD; Ventura M; Duc HT; Maillet F; Thobie N; Liacopoulos P
    J Immunol; 1985 Jan; 134(1):486-91. PubMed ID: 3917282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trinitrophenylated red cells (E-TNP) as a model for antibody-independent activation of the complement system via the classical pathway.
    Loos M; Thesen R
    J Immunol; 1978 Jul; 121(1):24-8. PubMed ID: 670702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation is not required for IgG-mediated suppression of the antibody response.
    Heyman B; Wiersma E; Nose M
    Eur J Immunol; 1988 Nov; 18(11):1739-43. PubMed ID: 3060362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse monoclonal antibodies at the red cell surface--II. Effect of hapten density on complement fixation and activation.
    Kratz HJ; Borsos T; Isliker H
    Mol Immunol; 1985 Mar; 22(3):229-35. PubMed ID: 4000127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of mouse complement by monoclonal mouse antibodies.
    Neuberger MS; Rajewsky K
    Eur J Immunol; 1981 Dec; 11(12):1012-6. PubMed ID: 7327198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of mouse complement by different classes of mouse antibody.
    Klaus GG; Pepys MB; Kitajima K; Askonas BA
    Immunology; 1979 Dec; 38(4):687-95. PubMed ID: 521057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA:IgM and IgA:IgA hybrid hybridomas secrete heteropolymeric immunoglobulins that are polyvalent and bispecific.
    Urnovitz HB; Chang Y; Scott M; Fleischman J; Lynch RG
    J Immunol; 1988 Jan; 140(2):558-63. PubMed ID: 3335782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
    Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
    Wright A; Morrison SL
    J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
    Levy NJ; Kasper DL
    J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C4 does not bind to human and rabbit IgM during activation of the classical complement pathway on the red cell.
    Circolo A; Borsos T
    J Immunol; 1982 Oct; 129(4):1485-8. PubMed ID: 7108214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative influence of antibody and complement coating of red cells on monocyte-mediated cell lysis.
    Kurlander RJ; Rosse WF; Logue GL
    J Clin Invest; 1978 May; 61(5):1309-19. PubMed ID: 96137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of the human complement subcomponent C1q to hybrid mouse monoclonal antibodies.
    Koolwijk P; Boot JH; Griep R; Bast BJ
    Mol Immunol; 1991 Jun; 28(6):567-76. PubMed ID: 1861677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of immunoglobulin G1 structure on macrophage binding to supported planar lipid monolayers.
    Kimura K; Nakanishi M; Ueda M; Ueno J; Nariuchi H; Furukawa S; Yasuda T
    Immunology; 1986 Oct; 59(2):235-8. PubMed ID: 3770803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis.
    Berman S; Gewurz H; Mold C
    J Immunol; 1986 Feb; 136(4):1354-9. PubMed ID: 3944459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.